Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.5 SEK | +3.20% |
|
+2.15% | +9.53% |
01/07 | Active Biotech Enters Agreement for A Clinical Study of Tasquinimod in Myelofibrosis | CI |
22/05 | Active Biotech Secures Exclusive Licensing Rights to Multiple Myeloma Drug | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
ACTIVE BIOTECH AB | Bio Therapeutic Drugs | +3.20% | +2.15% | +9.53% | -40.19% | -83.74% | 17.25M | ![]() | ![]() | ![]() |
- Stock Market
- Equities
- ACTI Stock
- Charts Active Biotech AB
- Relative Strength Chart